Literature DB >> 30574503

Serum Albumin at Start of Peritoneal Dialysis Predicts Long-Term Outcomes in Anhui Han Patients on Continuous Ambulatory Peritoneal Dialysis: A Retrospective Cohort Study.

Jun Jiang1, Li-Hua Wang1, Yun-Yun Fei1, Xiao-Wan Zhou1, Li Peng1, Lei Lan1, Wei Ren1.   

Abstract

OBJECTIVE: This study assessed the relationship between serum albumin (ALB) at start of peritoneal dialysis (PD) and long-term outcomes of continuous ambulatory PD (CAPD) in Anhui Han patients.
METHODS: A total of 149 Anhui Han CAPD patients were enrolled in this study and followed up for 3 years. They were initially diagnosed with the end-stage renal disease and underwent surgical PD catheter placement from January 2009 to December 2013. According to serum ALB at start of PD, the patients were divided into two groups: low ALB group (ALB < 35 g/L) and high ALB group (ALB ≥35 g/L). Demographic, hematologic, biochemical, and dialysis-related data were collected. Kaplan-Meier survival analysis and log-rank test were conducted to compare patient mortality, cardiovascular mortality and technique failure between the low ALB group and the high ALB group. Cox regression analysis was performed to analyze the risk factors, calculate the hazard ratio (HR), adjusted HR (AHR) and 95% confidence interval (CI).
RESULTS: The low ALB group showed a greater number of diabetes mellitus compared with the high ALB group. Patient mortality, cardiovascular mortality, and technique failure in the high ALB group were significantly lower than those in the low ALB group. In Cox regression analysis, serum ALB < 35 g/L was an independent predictor of patient mortality (AHR 3.043, 95% CI 1.085-8.536, p = 0.034), cardiovascular mortality (AHR 11.587, 95% CI 1.466-91.574, p = 0.020), and technique failure (AHR 3.148, 95% CI 1.603-6.182, p = 0.001) in CAPD patients after adjustment for sex, age, estimated glomerular filtration rate, primary renal disease, diabetes mellitus, and cardiovascular disease.
CONCLUSIONS: In Anhui Han patients on CAPD, the levels of serum ALB at start of PD are inversely correlated with patient mortality, cardiovascular mortality, and technique failure, and the long-term outcomes of patients with hypoalbuminemia at start of PD are poor. To improve the long-term outcomes of Anhui Han CAPD patients, patients with hypoalbuminemia at start of PD should be closely monitored.

Entities:  

Keywords:  Cardiovascular mortality; Patient mortality; Peritoneal dialysis; Serum albumin; Technique failure

Year:  2018        PMID: 30574503      PMCID: PMC6276754          DOI: 10.1159/000492426

Source DB:  PubMed          Journal:  Kidney Dis (Basel)        ISSN: 2296-9357


  27 in total

1.  Does a hyperoncotic cardiopulmonary bypass prime affect extravascular lung water and cardiopulmonary function in patients undergoing coronary artery bypass surgery?

Authors:  G P Eising; M Niemeyer; T Günther; P Tassani; M Pfauder; H Schad; R Lange
Journal:  Eur J Cardiothorac Surg       Date:  2001-08       Impact factor: 4.191

Review 2.  Role of hypoalbuminemia in the genesis of cardiovascular disease in dialysis patients.

Authors:  S B Kim; W S Yang; J S Park
Journal:  Perit Dial Int       Date:  1999       Impact factor: 1.756

Review 3.  Congestion is an important diagnostic and therapeutic target in heart failure.

Authors:  Mihai Gheorghiade; David D Shin; Tarita O Thomas; Filippo Brandimarte; Gregg C Fonarow; William T Abraham
Journal:  Rev Cardiovasc Med       Date:  2006       Impact factor: 2.930

4.  Long-term CAPD survival and analysis of mortality risk factors: 12-year experience of a single Mexican center.

Authors:  A M Cueto-Manzano; E Quintana-Piña; R Correa-Rotter
Journal:  Perit Dial Int       Date:  2001 Mar-Apr       Impact factor: 1.756

5.  Peritoneal dialysis in the US: evaluation of outcomes in contemporary cohorts.

Authors:  S Mujais; K Story
Journal:  Kidney Int Suppl       Date:  2006-11       Impact factor: 10.545

6.  Patient and physician predictors of peritoneal dialysis technique failure: a population based, retrospective cohort study.

Authors:  Mala Chidambaram; Joanne M Bargman; Robert R Quinn; Peter C Austin; Janet E Hux; Andreas Laupacis
Journal:  Perit Dial Int       Date:  2010-10-14       Impact factor: 1.756

7.  Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volume.

Authors:  Christopher Adlbrecht; Spyridoula Kommata; Martin Hülsmann; Thomas Szekeres; Christian Bieglmayer; Guido Strunk; Georgios Karanikas; Rudolf Berger; Deddo Mörtl; Kurt Kletter; Gerald Maurer; Irene M Lang; Richard Pacher
Journal:  Eur Heart J       Date:  2008-08-12       Impact factor: 29.983

8.  The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial.

Authors:  L H Kuller; J E Eichner; T J Orchard; G A Grandits; L McCallum; R P Tracy
Journal:  Am J Epidemiol       Date:  1991-12-01       Impact factor: 4.897

9.  Patient and technique survival on peritoneal dialysis in the United States: evaluation in large incident cohorts.

Authors:  Amy Guo; Salim Mujais
Journal:  Kidney Int Suppl       Date:  2003-12       Impact factor: 10.545

10.  Long-term clinical outcomes of peritoneal dialysis patients: single center experience from Korea.

Authors:  Seung Hyeok Han; Jung Eun Lee; Dong Ki Kim; Sung Jin Moon; Hyun-Wook Kim; Jae Hyun Chang; Beom Seok Kim; Shin-Wook Kang; Kyu Hun Choi; Ho Yung Lee; Dae Suk Han
Journal:  Perit Dial Int       Date:  2008-06       Impact factor: 1.756

View more
  7 in total

1.  Comparison of clinical features and outcomes in peritoneal dialysis-associated peritonitis patients with and without diabetes: A multicenter retrospective cohort study.

Authors:  Ling-Fei Meng; Li-Ming Yang; Xue-Yan Zhu; Xiao-Xuan Zhang; Xin-Yang Li; Jing Zhao; Shi-Chen Liu; Xiao-Hua Zhuang; Ping Luo; Wen-Peng Cui
Journal:  World J Diabetes       Date:  2020-10-15

2.  Serum Phosphorus and Albumin in Patients Undergoing Peritoneal Dialysis: Interaction and Association With Mortality.

Authors:  Naya Huang; Huiyan Li; Li Fan; Qian Zhou; Dongying Fu; Lin Guo; Chunyan Yi; Xueqing Yu; Haiping Mao
Journal:  Front Med (Lausanne)       Date:  2021-12-01

3.  Serum albumin at 1 year after peritoneal dialysis predicts long-term outcomes on continuous ambulatory peritoneal dialysis.

Authors:  Li Jin; Xiaopei Wang; Ying Ma; Jie Zheng; Wanhong Lu; Liyi Xie; Jing Lv
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

4.  Dynamic serum albumin and outcome of peritoneal dialysis patients: A retrospective study in China.

Authors:  Panai Song; Dong Yang; Jine Li; Ning Zhuo; Xiao Fu; Lei Zhang; Hongqing Zhang; Hong Liu; Lin Sun; Yinghong Liu
Journal:  Front Med (Lausanne)       Date:  2022-08-02

5.  Peritoneal Dialysis Modality Failure in a Middle-Income Country: A Retrospective Cohort Study.

Authors:  Jasmin I Vesga; Nelcy Rodriguez; Rafael M Sanabria
Journal:  Kidney Med       Date:  2021-02-17

6.  Effect of Serum Albumin Changes on Mortality in Patients with Peritoneal Dialysis: A Joint Modeling Approach and Personalized Dynamic Risk Predictions.

Authors:  Merve Basol; Dincer Goksuluk; Murat H Sipahioglu; Ergun Karaagaoglu
Journal:  Biomed Res Int       Date:  2021-07-21       Impact factor: 3.411

7.  The prognosis and risk factors of baseline high peritoneal transporters on patients with peritoneal dialysis.

Authors:  Guansen Huang; Yi Wang; Yingfeng Shi; Xiaoyan Ma; Min Tao; Xiujuan Zang; Yinghui Qi; Cheng Qiao; Lin Du; Lili Sheng; Shougang Zhuang; Na Liu
Journal:  J Cell Mol Med       Date:  2021-07-26       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.